Current Insights into the Management of Late Chemotherapy Toxicities in Pediatric Osteosarcoma Patients
Stefanie Hecker-Nolting,1 Thorsten Langer,2 Claudia Blattmann,1 Leo Kager,3 Stefan S Bielack1,4 1Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Zentrum für Kinder-, Jugend- und Frauenmedizin, Stuttgart Cancer Center, Klinikum Stuttgart – Olgahospital, Stuttgart, Germany; 2Pädiatrische Onkologie...
Saved in:
Main Authors: | Hecker-Nolting S, Langer T, Blattmann C, Kager L, Bielack SS |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b27011ce842b42a98e58b209f1f2fdd1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PATHOLOGICAL ASSESSMENTOF TUMOR RESPONSE IN A NEO-ADJUVANT THERAPY TREATED RESECTIONS FOR OSTEOSARCOMAS
by: Syed Gardezi Saad Gardezi, et al.
Published: (2018) -
Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy
by: Lu Zhang, et al.
Published: (2021) -
Tratamiento adyuvante (Conpadri I) en osteosarcoma infantil (Valdivia 1980-1990)
by: Zolezzi R,Paola, et al.
Published: (1992) -
Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center <sup>18</sup>F-FDG PET Images
by: Jingyu Kim, et al.
Published: (2021) -
Tumor Phyllodes con transformación a osteosarcoma
by: Nieto-Coronel,Tereza, et al.
Published: (2017)